Diffuse Large B-cell Lymphoma Prognosis Calculator

This calculator relies on the globally recognized Revised International Prognostic Index (R-IPI) or similar scoring frameworks for diffuse large B-cell lymphoma (DLBCL). Each clinical factor is assigned a specific point value based on its established statistical impact on patient survival. The fundamental equation is: Total Score = Age + Stage + LDH + Performance Status + Extranodal Sites. Each variable contributes 0 or 1 point depending on predefined clinical thresholds—such as age greater than 60 years or an elevated LDH level—yielding a cumulative integer that correlates directly with specific risk tiers and long-term survival probabilities.

Consider a 65-year-old patient diagnosed with DLBCL. Step 1: Age is over 60, assigning 1 point. Step 2: The disease is diagnosed at Ann Arbor Stage III, which assigns 1 point. Step 3: The patient's serum LDH level is elevated above normal limits, adding 1 point. Step 4: The Eastern Cooperative Oncology Group (ECOG) performance status is 2 (indicating the patient is ambulatory and capable of self-care but unable to work), adding 1 point. Step 5: There is involvement in one extranodal site, which contributes 0 points because the threshold is more than one site. Summing these values gives a Total Score of 4 + 0 = 4, placing the patient in a higher-risk category that guides intensive therapeutic decision-making.

Always utilize the most recent laboratory test results, as serum LDH levels can fluctuate based on immediate disease activity and inflammatory responses. Ensure that performance status evaluations reflect the patient's baseline functionality over the preceding weeks rather than a temporary acute setback. Most importantly, remember that prognostic indices are statistical averages derived from large populations and cannot predict an individual patient's exact response to modern chemoimmunotherapy regimens.